Company Filing History:
Years Active: 2017
Title: **Inventor Spotlight: Christopher D Wassman**
Introduction
Christopher D Wassman, an innovative inventor based in San Francisco, California, has made significant contributions to the field of molecular biology. With his expertise in enhancing p53 activity, Wassman's work stands at the intersection of drug development and cancer research. His unique approach has provided new insights into therapeutic methods for p53 mutant polypeptides.
Latest Patents
Wassman holds a patent titled "Small molecules to enhance P53 activity." This patent outlines a method for enhancing the activity of a p53 mutant polypeptide by introducing a compound that interacts with an open L1/S3 binding site. The significance of this innovation lies in its potential to augment p53 activity, which is crucial for tumor suppression. The patent details the identification of compounds through virtual drug screening and presents methods for screening these compounds, alongside treatment methodologies utilizing the discovered compounds.
Career Highlights
Currently, Christopher D Wassman is affiliated with the University of California, where he engages in groundbreaking research. His academic position allows him to collaborate with other esteemed professionals in the field. Through rigorous research and development, Wassman continues to contribute to the advancement of molecular biology.
Collaborations
Wassman collaborates with notable colleagues, including Rommie E Amaro and Roberta Baronio. These partnerships not only enhance the research environment but also foster innovative approaches to addressing critical issues in cancer treatment and drug discovery.
Conclusion
Christopher D Wassman's commitment to enhancing p53 activity through innovative methods highlights his role as a forward-thinking inventor. His work at the University of California reflects the importance of collaboration and research in developing effective treatments for cancer. As he continues to explore the potential of small molecules in healthcare, Wassman's contributions are poised to make an enduring impact in the field.